Choose your preferred way to stay informed of new case launches and settlement deadlines
Enfusion conducted its initial public offering ("IPO") on or around October 21, 2021, selling 15.32 million shares of stock priced at $17.00 per share. Then, on August 6, 2024, Enfusion issued a press release reporting its financial results for the second quarter of 2024. Among other items, Enfusion reported non-GAAP earnings per share of $0.05, missing consensus estimates by $0.01, as well as revenue of $49.5 million, missing consensus estimates by approximately $475,000. Following this news, Enfusion's stock price dropped over 7% on August 6, 2024.
In order to be eligible to join the ENFN class action lawsuit, you must have incurred a loss on shares of Enfusion purchased during the class period listed above.
TOP
